Shanghai Tenth People's Hospital
Shanghai 200072
5 studies enrolling now · 12 studies all time
What they study most
Acute Myocardial Infarction, Atrial Fibrillation, Branch Retinal Vein Occlusion, Carcinoma, Transitional Cell, Central Retinal Vein Occlusion, Diabetic Macular Edema, Endometrial Cancer, Generalized Pustular Psoriasis, Hemiretinal Vein Occlusion, Kidney Disease, Chronic, Macular Edema, Neoplasm Metastasis
Studies at this site
- LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis — Recruiting now
- Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer — Recruiting now
- A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract — Recruiting now
- EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) — Recruiting now
- A Study to Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis (GPP) Who Need Treatment for Repeated Flares — Running, not enrolling
- Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26) — Running, not enrolling
- Selatogrel Outcome Study in Suspected Acute Myocardial Infarction — Enrolling by invitation
- Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC — Running, not enrolling
- Cryo Global Registry — Completed
- A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema — Completed
- A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion — Completed
- A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion — Completed